Theresa A. Mcdonagh
#155,417
Most Influential Person Now
Theresa A. Mcdonagh's AcademicInfluence.com Rankings
Theresa A. Mcdonaghmedical Degrees
Medical
#3041
World Rank
#3492
Historical Rank
Cardiology
#307
World Rank
#315
Historical Rank
Download Badge
Medical
Why Is Theresa A. Mcdonagh Influential?
(Suggest an Edit or Addition)Theresa A. Mcdonagh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2010) (4824)
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. (2021) (2883)
- 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. (2016) (2682)
- [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. (2015) (2327)
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (2221)
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (2015) (2007)
- 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† (2014) (837)
- State of the art: Using natriuretic peptide levels in clinical practice (2008) (780)
- Third universal definition of myocardial infarction. (2012) (751)
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population (1997) (663)
- Randomised controlled trial of specialist nurse intervention in heart failure (2001) (586)
- Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology (2009) (484)
- 213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (484)
- Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (2019) (469)
- Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology (2018) (436)
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) (402)
- A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. (2013) (379)
- Trends in hospitalization for heart failure in Scotland 1980-1990. (1993) (375)
- Self‐care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology (2011) (356)
- Clinical applications of B-type natriuretic peptide (BNP) testing. (2003) (355)
- Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction (2003) (352)
- N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. (2003) (342)
- Recommendations on pre‐hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine (2015) (323)
- Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population (2001) (278)
- The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study (2005) (274)
- Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. (1999) (262)
- European Society of Cardiology Heart Failure Association Standards for delivering heart failure care (2011) (223)
- Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure (2006) (210)
- Morphine for the relief of breathlessness in patients with chronic heart failure—a pilot study (2002) (204)
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2022) (201)
- Electrocardiographic abnormalities and uremic cardiomyopathy. (2005) (197)
- The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. (1999) (183)
- Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. (2015) (174)
- The role of apelin in cardiovascular function and heart failure (2008) (168)
- Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. (2016) (155)
- Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology (2019) (155)
- Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. (1999) (151)
- Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? (1998) (149)
- The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic (2020) (146)
- Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. (2003) (146)
- Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version. (2015) (144)
- The national heart failure audit for England and Wales 2008–2009 (2010) (143)
- Biological Phenotypes of Heart Failure With Preserved Ejection Fraction. (2017) (142)
- The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure (2006) (130)
- NT‐proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies (2004) (130)
- 2010 Focused Update of ESC Guidelines on device therapy in heart failure (2010) (128)
- Heart Failure Epidemiology: European Perspective (2013) (126)
- Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. (1998) (118)
- Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? (2015) (110)
- Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis (2017) (110)
- UK guidelines for referral and assessment of adults for heart transplantation (2011) (108)
- Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. (2007) (103)
- Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. (2002) (101)
- Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice (1997) (98)
- Erratum : 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (2015) (94)
- NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. (2003) (92)
- Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK (2009) (89)
- Plasma apelin concentration is depressed following acute myocardial infarction in man (2009) (86)
- Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. (2011) (86)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice (2018) (82)
- Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic (2020) (82)
- Temporal trends in decompensated heart failure and outcomes during COVID‐19: a multisite report from heart failure referral centres in London (2020) (81)
- Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency. (2019) (80)
- Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure (2007) (76)
- Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. (2006) (76)
- Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis (2011) (72)
- Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups (2013) (72)
- Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency (2016) (71)
- Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry (2020) (67)
- Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. (1997) (61)
- International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients (2019) (58)
- Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry (2019) (57)
- Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy. (2018) (56)
- Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum (2016) (54)
- Preliminary experience of 99mTc‐Aprotinin scintigraphy in amyloidosis (2007) (52)
- Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy (2011) (51)
- Heart Failure Association of the European Society of Cardiology Specialist Heart Failure Curriculum (2014) (47)
- Mode of death in patients with newly diagnosed heart failure in the general population (2008) (47)
- Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition. (1998) (45)
- Rationale and design of the CONFIRM‐HF study: a double‐blind, randomized, placebo‐controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency (2014) (45)
- Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies (2002) (45)
- Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis. (2014) (45)
- ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects. (2001) (44)
- A change in N‐terminal pro‐brain natriuretic peptide is predictive of outcome in patients with advanced heart failure (2007) (42)
- Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial (2019) (42)
- Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction. (2010) (40)
- Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round‐table think tank on acute heart failure, 12 May 2009 (2011) (40)
- The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease (2003) (39)
- Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic (2021) (39)
- Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
- Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review. (2015) (38)
- Less invasive ventricular reconstruction for ischaemic heart failure (2019) (37)
- The healthcare costs of heart failure during the last five years of life: A retrospective cohort study (2016) (37)
- Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. (2007) (37)
- The year in cardiology: heart failure. (2020) (34)
- Fully automatic left ventricular boundary extraction in echocardiographic images (1995) (33)
- Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure (2019) (33)
- Erythrocyte Transketolase Activity, Markers of Cardiac Dysfunction and the Diagnosis of Infantile Beriberi (2011) (33)
- Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world (2019) (32)
- A meta-analysis of echocardiographic measurements of the left heart for the development of normative reference ranges in a large international cohort: the EchoNoRMAL study. (2014) (31)
- N‐terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin‐1, adrenomedullin and tumour necrosis factor‐α in patients referred for consideration of cardiac transplantation (2005) (31)
- Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy (2003) (31)
- B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data (2018) (30)
- Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction (2021) (30)
- Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure (2005) (29)
- The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones? (2005) (29)
- Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study (2016) (29)
- Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry (2020) (28)
- Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure. (2015) (27)
- Oxford Textbook of Heart Failure (2011) (26)
- Utility of overnight pulse oximetry and heart rate variability analysis to screen for sleep-disordered breathing in chronic heart failure (2012) (26)
- N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation (2005) (24)
- EACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting. (2016) (24)
- The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failure. (2013) (24)
- Screening for asymptomatic left ventricular dysfunction using B-type natriuretic Peptide. (2008) (24)
- Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model. (2017) (23)
- Newly diagnosed heart failure: change in quality of life, mood, and illness beliefs in the first 6 months after diagnosis. (2012) (23)
- The Role of Intravenous Vasodilators in Acute Heart Failure Management (2014) (22)
- Asymptomatic left ventricular dysfunction in the community (2000) (22)
- N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure. (2005) (21)
- Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis (2021) (21)
- Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
- Who needs a heart transplant? (2006) (20)
- Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales) (2017) (19)
- Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?☆ (2018) (19)
- Biologic Variability of Soluble ST2 in Patients With Stable Chronic Heart Failure and Implications for Monitoring. (2016) (19)
- Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study (2018) (19)
- Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Research Programme Heart Failure Long‐Term Registry (2020) (18)
- Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure (2016) (18)
- Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan (2018) (18)
- Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales (2016) (17)
- The collateral cardiovascular damage of COVID-19: only history will reveal the depth of the iceberg (2021) (16)
- Chronic heart failure: epidemiology, investigation and management (2014) (15)
- Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis. (2012) (15)
- Chemotherapy-related Cardiomyopathy. (2015) (14)
- B-type natriuretic peptides in heart failure. (2007) (14)
- In‐hospital worsening heart failure: a clinically relevant endpoint? (2017) (13)
- Importance of β blockade in the treatment of advanced heart failure (2003) (13)
- Lessons from the management of chronic heart failure (2005) (13)
- Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure (2014) (12)
- Measurement of brain natriuretic peptide (1996) (12)
- Novel biomarkers in heart failure: an overview. (2009) (11)
- Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care (2007) (11)
- Recommendations on the clinical use of B-type natriuretic peptide testing (BNP or NTproBNP) in the UK and Ireland (2010) (11)
- Long‐term outcomes after heart failure hospitalization during the COVID‐19 pandemic: a multisite report from heart failure referral centers in London (2021) (11)
- Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study. (2016) (11)
- Pulmonary hypertension in left heart disease: a review. (2012) (10)
- A reduction in total isovolumic time with cardiac resynchronisation therapy is a predictor of clinical outcomes. (2013) (10)
- Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community. (2004) (10)
- 6 Comparing echocardiography and cardiac magnetic resonance measures of ejection fraction: implications for HFMRF research (2018) (10)
- Mortality after admission for heart failure in the UK compared with Japan (2018) (9)
- The treatment of chronic heart failure due to left ventricular systolic dysfunction. (2004) (9)
- The reproducibility of symptoms during a submaximal exercise test in chronic heart failure. (1998) (9)
- Do plasma concentrations of apelin predict prognosis in patients with advanced heart failure? (2014) (9)
- Dynamic transcatheter mitral valve repair: a new concept to treat functional mitral regurgitation using an adjustable spacer. (2017) (9)
- Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol (2002) (8)
- MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care☆☆☆ (2017) (8)
- Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit (2019) (7)
- Can geriatricians improve inpatient heart failure care? Time for a heart to heart. (2012) (7)
- Declining renal function after myocardial infarction predicts poorer long-term outcome (2010) (7)
- The impact of catheter ablation for atrial fibrillation in heart failure (2018) (7)
- Heart failure specialization in Europe (2016) (7)
- N-terminal brain natriuretic peptide: The new gold standard in predicting mortality in patients with advanced heart failure (2003) (7)
- Screening for left ventricular dysfunction: a step too far? (2002) (7)
- Emerging role of the apelin system in cardiovascular homeostasis. (2007) (7)
- Global left ventricular systolic dysfunction in North Glasgow (1996) (6)
- Heart failure and chemotherapeutic agents. (2015) (6)
- Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes (2021) (6)
- Cardiology after COVID-19: Quo Vademus? (2020) (5)
- The impact of age on clinical outcomes following cardiac resynchronisation therapy (2013) (5)
- Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control (2016) (5)
- Ironing out iron deficiency in heart failure (2016) (4)
- Challenges in advanced chronic heart failure: drug therapy. (2008) (4)
- Consensus statement on management of chronic heart failure in India (2015) (4)
- 50 Biological Variability of Soluble ST2 in Stable Chronic Heart Failure (2014) (4)
- From Coronary Care Unit to Acute Cardiac Care Unit – the evolving role of specialist cardiac care: Recommendations of the British Cardiovascular Society Working Group on Acute Cardiac Care (2011) (4)
- ST2 in patients with severe aortic stenosis and heart failure. (2013) (4)
- Palliative Care in Acute Heart Failure (2020) (4)
- The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure (2006) (4)
- Comparison of the Diagnostic Accuracy of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Patients <80 to those >80 Years of Age with Heart Failure. (2018) (4)
- Development, validation and implementation of biomarker testing in cardiovascular medicine state-of-the-art: Proceedings of the European Society of Cardiology - Cardiovascular Round Table. (2020) (4)
- The year in cardiology: heart failure. The year in cardiology 2019. (2020) (3)
- Cardiotoxicity of Chemotherapeutic Drugs: An Update and Future Perspectives. (2022) (3)
- Thiazolinediones and heart failure: the potential to precipitate irreversible cardiac dysfunction. (2008) (3)
- The reign of the natriuretic peptides in patients with heart failure continues. (2008) (3)
- The 'Ten Commandments' of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. (2021) (3)
- Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis (2017) (3)
- Serial soluble ST 2 for the monitoring of pharmacologically optimised chronic stable heart failure (2014) (3)
- Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
- Association between ethnicity and degree of improvement in cardiac function following initiation of sacubitril/valsartan. (2021) (2)
- The ACE I/D polymorphism and mortality: A population-based study (1999) (2)
- Heart failure: epidemiology, investigation and management (2010) (2)
- A consensus statement from representatives of the British Society of Echocardiography , British Heart Failure Society , CHD collaborative and Primary Care Cardiovascular Society (2011) (2)
- Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology (2022) (2)
- Cardio-pulmonary exercise testing (2014) (2)
- Natriuretic peptides, left ventricular dysfunction and mortality: A population-based study (1998) (2)
- LEFT-VENTRICULAR DYSFUNCTION. AUTHORS' REPLY (1998) (2)
- Treatment of left ventricular non-compaction with cardiac resynchronization therapy. (2013) (2)
- Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy: comparison of the performance of four risk scoring systems (2017) (2)
- 597 Can we use BNP and NTproBNP to rule out heart failure in clinical practice? Results of the UK natriuretic peptide study (2003) (2)
- New horizons in cardiogeriatrics: geriatricians and heart failure care-the custard in the tart, not the icing on the cake. (2021) (2)
- Importance of b blockade in the treatment of advanced heart failure (2003) (1)
- S16 Detection of sleep-disordered breathing in chronic heart failure patients: utility of heart rate variability versus pulse oximetry? (2010) (1)
- The investigation and treatment of chronic heart failure (2006) (1)
- COVID‐19 and heart failure: the dark side of the moon (2022) (1)
- Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy – ERRATUM (2021) (1)
- Can we use B-type natriuretic peptides to monitor patients with heart failure? (2007) (1)
- Prevalence, correlates, effects and detection of left ventricular systolic dysfunction in an urban population (1999) (1)
- N‐terminal pro BNP and the prognosis of left ventricular dysfunction in a population‐based study (2000) (1)
- Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure (2022) (1)
- N-terminal pro BNP: Role in diagnosis of left ventricular dysfunction in a population-based study (2000) (1)
- A cost effectiveness study establishing the impact and accuracy of implementing the NICE guidelines lowering plasma NTproBNP threshold in patients with clinically suspected heart failure at our institution. (2018) (1)
- Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482‐489] (2016) (1)
- Diagnosis and investigation (2014) (1)
- Part XII Medical therapy for acute heart failure (2011) (1)
- The Year in Cardiology 2012: heart failure. (2013) (1)
- P4373Effects of drug treatment on clinical outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials (2017) (1)
- The patient with CHF and cancer (2014) (1)
- Utility Of Pulse Oximetry Versus Heart Rate Variability To Screen For Sleep-Disordered Breathing In Chronic Heart Failure (2011) (1)
- N-T Pro-BNP is a powerful predictor of outcome in patients with stable angina: A substudy of the IONA trial (2003) (1)
- Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension. (2022) (1)
- Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency: Rationale and design of CONFIRM-HF study (2014) (1)
- The Authors' reply (2011) (0)
- 607 Renal dysfunction, as measured by the Modification of Diet in Renal Disease (MDRD) equations, and outcome in patients with advanced heart failure (2006) (0)
- 13 Novel Biomarkers in Assessing Outcome in Patients with Severe Aortic Stenosis and Heart Failure (2016) (0)
- Chapter 12 The patient with CHF and arthritis (2007) (0)
- 68 Implantable cardioverter-defibrillator deactivation in the community: the perspective of palliative care professionals (2021) (0)
- Socioeconomically but not medically deprived? (2012) (0)
- The patient with CHF and arthritis (2014) (0)
- Chapter 5 Pharmacological management (2007) (0)
- Chapter 34 Angiotensin receptor antagonists (2007) (0)
- Part XI Medical therapy for chronic heart failure (2011) (0)
- Chapter 21 The patient with CHF and sleep-disordered breathing (2007) (0)
- The pregnant patient with HF (2014) (0)
- Chapter 36 Inotropes and vasopressors (2007) (0)
- Part II Epidemiology (2011) (0)
- 43 Acute Heart Failure: Where did We Get Wrong? (2015) (0)
- 14 Cardiac natriuretic peptides and heart failure (2011) (0)
- Chapter 38 Heart failure services (2007) (0)
- Chapter 20 The patient with CHF and preserved LV systolic function (2007) (0)
- CRT Optimization (0)
- Part VIII Invasive investigation (2011) (0)
- Diuretics and aquaretics (2014) (0)
- The year in cardiology: heart failure The year in cardiology 2019 (2020) (0)
- Chapter 7 Coronary revascularization in heart failure (2007) (0)
- PCV31 - A Model-Based Cost-Effectiveness Analysis of B-Type Natriuretic Peptide Monitoring in Patients with Heart Failure (2016) (0)
- DIFFICULT CASE OF CARDIAC PACING POST-MYOCARDITIS IN A YOUNG MAN (2016) (0)
- β-adrenoreceptor antagonists (2014) (0)
- Chapter 18 The patient with CHF and valvular heart disease (2007) (0)
- Compendium of Abridged ESC Guidelines 2011 (2012) (0)
- Chapter 1 Definition, epidemiology, and pathophysiology (2007) (0)
- Guidelines on the identification and treatment of pulmonary hypertension. (2009) (0)
- Part VII Noninvasive investigation (2011) (0)
- Part X Comorbidities: the patients with heart failure and... (2011) (0)
- The patient with CHF and anaemia (2014) (0)
- 373 The integration of a specialist heart failure nurse into a clinic for incident cases of suspected heart failure (2003) (0)
- 77 Contemporary prognosis of patients hospitalised with a primary diagnosis of heart failure: the national heart failure audit of england & wales (2019) (0)
- Mechanical circulatory support (2014) (0)
- Definition of heart failure, basic epidemiology, and pathophysiology (2014) (0)
- Inotropes and vasopressors (2014) (0)
- Intravenous iron passes another endurance test in heart failure (2022) (0)
- Epidemiology of heart failure (2018) (0)
- How the on-going conflict in Ukraine is impacting cardiovascular health? (2022) (0)
- CHF and adult congenital heart disease (2014) (0)
- British Society of Heart Failure 2009 meeting report (2010) (0)
- Chapter 26 Cardiac catheterization (2007) (0)
- The Year in Cardiology The Year in Cardiology 2012 : heart failure (2013) (0)
- Exploring the prevalence, impact and experience of cardiac cachexia in patients with advanced heart failure and their caregivers: A sequential phased study (2022) (0)
- BIOCHEMICAL DETECTION OF SYSTOLIC DYSFUNCTION. AUTHORS' REPLY (1998) (0)
- Chapter 32 β-adrenoreceptor antagonists (2007) (0)
- How Often Do Mixed Apneas Occur In Chronic Heart Failure Patients And What Is Their Impact On Diagnosis Of Sleep-Disordered Breathing? (2010) (0)
- Angiotensin receptor antagonists (2014) (0)
- Acute heart failure: management (2014) (0)
- Chapter 2 Diagnosis and investigation (2007) (0)
- Chapter 23 Acute heart failure: from definition to diagnosis (2007) (0)
- Combination diuretic therapy for acute heart failure: ‘alone we can do so little; together we can do so much’ (2022) (0)
- Brain natriuretic peptide: A blood test for the diagnosis of heart failure and monitoring of its treatment? (2003) (0)
- Chapter 28 IABP insertion (2007) (0)
- Chapter 39 Palliative care (2007) (0)
- Delivering heart failure care (2009) (0)
- Chapter 29 Cardiopulmonary exercise testing (2007) (0)
- 565 N‐terminal brain natriuretic peptide is an independent predictor of mortality in patients with advanced heart failure (2003) (0)
- Coronary revascularization in heart failure (2014) (0)
- Mineralocorticoid receptor antagonists (MRAs) (2014) (0)
- Chapter 24 Acute heart failure: management (2007) (0)
- Chapter 6 Device therapy in CHF (2007) (0)
- Can BNP or NT-pro-BNP be considered surrogate end points for heart failure? (2010) (0)
- Chapter 35 Diuretics (2007) (0)
- Central venous cannulation (2014) (0)
- The patient with CHF and preserved LV systolic function (HF-PEF) (2014) (0)
- The patient with CHF and renal dysfunction (2014) (0)
- Part XV Surgical therapy for heart failure (2011) (0)
- Chapter 8 Other surgical techniques (2007) (0)
- Epidemiology and general pathophysiological classification of heart failure (2020) (0)
- 17 Diagnosing heart failure (2011) (0)
- The patient with CHF and arrhythmias (2014) (0)
- Chapter 16 The patient with CHF and obstructive lung disease (2007) (0)
- Part XVIII Future therapies (2011) (0)
- Heart Failure (2014) (0)
- Rate limiting therapy (2014) (0)
- Chapter 22 The patient with CHF and cancer (2007) (0)
- Guidelines on diagnosis and conduct of syncope (version 2009) (2009) (0)
- Abstract 5898: The Reduction of Myocardial Apelin Production in Humans with Systolic Left Ventricular Dysfunction (2008) (0)
- 13 The pathophysiology of heart failure (2011) (0)
- Part XIV Device therapy for heart failure (2011) (0)
- Comprar Heart Failure | Roy S. Gardner | 9780199205738 | Oxford University Press (2007) (0)
- Implementation of the Mental Capacity Act: a national observational study comparing resultant trends in place of death for older heart failure decedents with or without comorbid dementia (2022) (0)
- Implementation of the Mental Capacity Act: a national observational study of changes in place of death for older heart failure patients with or without comorbid dementia (2021) (0)
- The year in cardiology 2019: heart failure (2020) (0)
- Overweight People The Lys 198 Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood (1999) (0)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 ESC heart failure guidelines into clinical practice: (2018) (0)
- Part IV Pathophysiology of heart failure: cellular and molecular changes (2011) (0)
- Hypertension was the most common cause of congestive heart failure. (1997) (0)
- Chapter 27 Endomyocardial biopsy (2007) (0)
- P17. The relationship between reversible myocardial perfusion defects and symptoms in heart failure due to ischaemic heart disease (2003) (0)
- Chapter 14 The patient with CHF and adult congenital heart disease (2007) (0)
- Chapter 10 The patient with CHF and angina (2007) (0)
- Additional file 3: of B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data (2018) (0)
- Chapter 9 Cardiac transplantation (2007) (0)
- P230 End-of-Life Care in Patients with Cardiac Devices (2016) (0)
- Do Hypopnea Scoring Criteria Affect Diagnosis of Sleep Apnea in Heart Failure Patients (2009) (0)
- Chapter 31 ACE inhibitors (2007) (0)
- Chapter 30 Assessment of dyssynchrony (2007) (0)
- Device therapy: which devices and for whom? (2014) (0)
- The patient with CHF and diabetes (2014) (0)
- Chapter 37 Vasodilators (2007) (0)
- Other surgical techniques (2014) (0)
- Chapter 3 Estimating prognosis (2007) (0)
- Chapter 17 The patient with CHF and renal dysfunction (2007) (0)
- Prospective screening of Afro-Caribbean heart failure patients to determine the prevalence of cardiac transthyretin (ATTR) amyloidosis (2013) (0)
- Part VI The diagnosis of heart failure (2011) (0)
- Part IX Prognostication (2011) (0)
- Non-pharmacological management (2014) (0)
- Part XVII Disease management (2011) (0)
- Acute heart failure: from definition to diagnosis (2014) (0)
- Chapter 13 The patient with CHF and anaemia (2007) (0)
- The patient with CHF and specific heart muscle disease (2014) (0)
- Heart failure services (2014) (0)
- 57 The future (2011) (0)
- Cardiovascular Damage in COVID-19: What We Know Two Years Later (2022) (0)
- Part XIII Nonpharmacological management (2011) (0)
- Abstract 12563: Variation in Referral for Specialist Follow-Up and 30-Day Mortality in Patients Hospitalized With Heart Failure in England and Wales (2014) (0)
- Chapter 15 The patient with CHF and diabetes mellitus (2007) (0)
- P2460Furosemide versus bumetanide; a deep dive into national heart failure audit (England & Wales) (2017) (0)
- Chapter 33 Aldosterone antagonists (2007) (0)
- P47 Impact of the mental capacity act on place of death in heart failure patients with or without comorbid dementia (2019) (0)
- Part V Pathophysiology of heart failure (2011) (0)
- The patient with CHF and valvular heart disease (2014) (0)
- The patient with CHF and angina (2014) (0)
- The impact and experience of cardiac cachexia in advanced heart failure patients and their caregivers. (2022) (0)
- Echocardiographic measures of left ventricular function and mortality: A population-based study (1999) (0)
- N-terminal brain natriuretic peptide can help to identify patients with a poorer outcome following cardiac transplantation (2004) (0)
- Part XVI Ventilatory strategies in heart failure (2011) (0)
- DOES THE SEVERITY OF PERIPHERAL OEDEMA AFFECT THE MORTALITY OF PATIENTS PRESENTING WITH ACUTE HEART FAILURE? A DEEP DIVE INTO THE NATIONAL HEART FAILURE AUDIT (2016) (0)
- Chapter 25 Central venous cannulation (2007) (0)
- Drug therapies for heart failure (2012) (0)
- Part I What is heart failure (2011) (0)
- 3 The epidemiology of heart failure (2011) (0)
- Part III The aetiology of heart failure (2011) (0)
- The patient with CHF and obstructive lung disease (2014) (0)
- 110 Improving temporal trends in survival for patients with newly diagnosed heart failure in the UK general population (2006) (0)
- Chapter 4 Non-pharmacological management (2007) (0)
- Hearts and Minds (2001) (0)
- 108 Progressive heart failure, rather than sudden death, accounts for most early deaths in patients with newly diagnosed heart failure (2006) (0)
- Chapter 19 The patient with CHF and specific heart muscle disease (2007) (0)
- Chapter 11 The patient with CHF and arrhythmias (2007) (0)
This paper list is powered by the following services:
